المؤلفون: McShane H; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX1 2JD, UK. Electronic address: helen.mcshane@ndm.ox.ac.uk.

المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jun; Vol. 24 (6), pp. 559-560. Date of Electronic Publication: 2024 Feb 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: BCG Vaccine*/immunology , BCG Vaccine*/administration & dosage , Immunization, Secondary* , Tuberculosis*/prevention & control, Humans

المؤلفون: Liao Y; Office of Emergency, Shenzhen Center for Disease Control and Prevention, Shenzhen, China., Su J; Department of Biochemistry, Changzhi Medical College, Changzhi, China., Zhao J; Department of Infectious Disease, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China., Qin Z; Class of 2002 of the Department of Preventive Medicine, Changzhi Medical College, Changzhi, China., Zhang Z; Class of 2002 of the Department of Preventive Medicine, Changzhi Medical College, Changzhi, China., Gao W; Office of Emergency, Shenzhen Center for Disease Control and Prevention, Shenzhen, China., Wan J; Office of Emergency, Shenzhen Center for Disease Control and Prevention, Shenzhen, China., Liao Y; Office of Emergency, Shenzhen Center for Disease Control and Prevention, Shenzhen, China., Zou X; Office of Emergency, Shenzhen Center for Disease Control and Prevention, Shenzhen, China., He X; Institute of Evidence-Based Medicine, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 31; Vol. 15, pp. 1359380. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/transmission , COVID-19*/immunology , COVID-19*/epidemiology , COVID-19*/virology , Immunization, Secondary* , SARS-CoV-2*/immunology , COVID-19 Vaccines*/immunology , Vaccines, Inactivated*/immunology, Humans ; Female ; Retrospective Studies ; Male ; China/epidemiology ; Adult ; Middle Aged ; Young Adult ; Aged ; Disease Susceptibility ; Adolescent ; Vaccine Efficacy ; Vaccination

SCR Organism: SARS-CoV-2 variants

المؤلفون: Ricke IJ; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA. Electronic address: ricke201@umn.edu., Spaulding AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Rajtar NN; Department of Plant Pathology, University of Minnesota, St. Paul, MN 55108, USA., Benton EM; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA., Anderson IG; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA., Lundberg L; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA., Mussiel A; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA., Nguyen RHN; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA.

المصدر: Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3499-3504. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Vaccines*/administration & dosage , COVID-19*/prevention & control , COVID-19*/epidemiology , Immunization, Secondary*/statistics & numerical data, Humans ; Minnesota ; Male ; Female ; Cross-Sectional Studies ; Adult ; Middle Aged ; Young Adult ; SARS-CoV-2/immunology ; Adolescent ; Intention ; Patient Acceptance of Health Care/statistics & numerical data ; Patient Acceptance of Health Care/psychology ; Aged ; Health Knowledge, Attitudes, Practice ; Surveys and Questionnaires

المؤلفون: Song S; Department of Biostatistics, College of Public Health and health Professions, University of Florida, Gainesville, FL, USA., Madewell ZJ; Department of Biostatistics, College of Public Health and health Professions, University of Florida, Gainesville, FL, USA., Liu M; Department of Statistics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA., Miao Y; Department of Statistics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA., Xiang S; Department of Statistics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA., Huo Y; Gilead Sciences, Inc, Foster City, CA, USA., Sarkar S; Department of Biostatistics, College of Public Health and health Professions, University of Florida, Gainesville, FL, USA., Chowdhury A; Department of Computer Science, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA., Longini IM Jr; Department of Biostatistics, College of Public Health and health Professions, University of Florida, Gainesville, FL, USA., Yang Y; Department of Statistics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA. Electronic address: yang.yang4@uga.edu.

المصدر: Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3389-3396. Date of Electronic Publication: 2024 Apr 22.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , COVID-19*/prevention & control , COVID-19*/immunology , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , Vaccine Efficacy* , Immunization, Secondary*/methods , mRNA Vaccines*, Humans ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/administration & dosage ; Middle Aged ; Adult

SCR Organism: SARS-CoV-2 variants

المؤلفون: Hamm SR; Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Loft JA; Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Pérez-Alós L; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Copenhagen University Hospital, 2200 Copenhagen, Denmark., Heftdal LD; Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Hansen CB; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Copenhagen University Hospital, 2200 Copenhagen, Denmark., Møller DL; Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Pries-Heje MM; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Hasselbalch RB; Department of Emergency Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark., Fogh K; Department of Emergency Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark., Hald A; Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Ostrowski SR; Department of Clinical Immunology, Section 2034, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Frikke-Schmidt R; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Sørensen E; Department of Clinical Immunology, Section 2034, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Hilsted L; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Bundgaard H; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Garred P; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Copenhagen University Hospital, 2200 Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Iversen K; Department of Emergency Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Perch M; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Sørensen SS; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Department of Nephrology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Rasmussen A; Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark., Sabin CA; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, UCL, Royal Free Campus, Rowland Hill St, London NW3 2PF, UK., Nielsen SD; Viro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.

المصدر: Viruses [Viruses] 2024 May 28; Vol. 16 (6). Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

مواضيع طبية MeSH: BNT162 Vaccine*/immunology , BNT162 Vaccine*/administration & dosage , COVID-19*/prevention & control , COVID-19*/immunology , Antibodies, Viral*/blood , Antibodies, Viral*/immunology , Immunity, Humoral* , Transplant Recipients* , SARS-CoV-2*/immunology , Immunization, Secondary* , Immunoglobulin G*/blood , Immunoglobulin G*/immunology , Organ Transplantation* , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Vaccination ; Spike Glycoprotein, Coronavirus/immunology

المؤلفون: Carnalla M; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico., Stern D; CONAHCyT-Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico., Arantxa Colchero M; Centro de Investigación en Evaluación y Encuestas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico., Rangel-Moreno K; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico., Basto-Abreu A; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico., Alpuche-Aranda CM; Centro de Investigación sobre Enfermedades Infecciosas. Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico., Bautista-Arredondo S; Centro de Investigación en Evaluación y Encuestas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico., Barrientos-Gutiérrez T; Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Mexico. Electronic address: tbarrientos@insp.mx.

المصدر: Vaccine [Vaccine] 2024 May 22; Vol. 42 (14), pp. 3273-3276. Date of Electronic Publication: 2024 Apr 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control , COVID-19 Vaccines*/administration & dosage , Immunization, Secondary*/statistics & numerical data , Latent Class Analysis*, Humans ; Male ; Female ; Mexico/epidemiology ; Middle Aged ; Aged ; SARS-CoV-2/immunology ; Vaccination Coverage/statistics & numerical data ; Rural Population/statistics & numerical data ; Aged, 80 and over ; Immunization Schedule ; Nutrition Surveys

المؤلفون: Kewcharoenwong C; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; The Centre for Research & Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.; Lanna Dog Welfare, Chiang Mai, Thailand., Freeouf S; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Nithichanon A; The Centre for Research & Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.; Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Petsophonsakul W; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; Lanna Dog Welfare, Chiang Mai, Thailand., Pornprasert S; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Khamduang W; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Onodera T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Takahashi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Lertmemongkolchai G; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand. ganja_le@kku.ac.th.; The Centre for Research & Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand. ganja_le@kku.ac.th.

المصدر: Medical microbiology and immunology [Med Microbiol Immunol] 2024 May 18; Vol. 213 (1), pp. 7. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0314524 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1831 (Electronic) Linking ISSN: 03008584 NLM ISO Abbreviation: Med Microbiol Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Rabies Vaccines*/immunology , Rabies Vaccines*/administration & dosage , Rabies*/prevention & control , Rabies*/immunology , Antibodies, Viral*/blood , Immunization, Secondary*, Thailand ; Humans ; Injections, Intradermal ; Animals ; Female ; Adult ; Male ; Young Adult ; Antibody Affinity ; Middle Aged ; Dogs ; Pre-Exposure Prophylaxis/methods ; Adolescent ; Post-Exposure Prophylaxis/methods ; Antibody Formation/immunology

المؤلفون: Zaeck LM; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Tan NH; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Rietdijk WJR; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Geers D; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Sablerolles RSG; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Bogers S; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van Dijk LLA; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Gommers L; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van Leeuwen LPM; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Rugebregt S; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Goorhuis A; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Infection and Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands., Postma DF; Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, the Netherlands., Visser LG; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Dalm VASH; Department of Internal Medicine, Division of Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Lafeber M; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Immunology and Infectious Diseases, University of Amsterdam, Amsterdam, the Netherlands., Huckriede ALW; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Haagmans BL; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Koopmans MPG; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van der Kuy PHM; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., GeurtsvanKessel CH; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands. c.geurtsvankessel@erasmusmc.nl., de Vries RD; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.

مؤلفون مشاركون: SWITCH-ON Research Group

المصدر: Nature communications [Nat Commun] 2024 May 18; Vol. 15 (1), pp. 4224. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/immunology , COVID-19*/prevention & control , COVID-19*/virology , SARS-CoV-2*/immunology , SARS-CoV-2*/genetics , Immunization, Secondary* , COVID-19 Vaccines*/immunology , COVID-19 Vaccines*/administration & dosage , Antibodies, Neutralizing*/immunology , Antibodies, Neutralizing*/blood , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , Immunogenicity, Vaccine*, Humans ; Female ; Male ; Adult ; Middle Aged ; Spike Glycoprotein, Coronavirus/immunology ; Spike Glycoprotein, Coronavirus/genetics ; T-Lymphocytes/immunology ; Vaccination

SCR Organism: SARS-CoV-2 variants

المؤلفون: Xie Z; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Lin YC; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Steichen JM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Ozorowski G; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Kratochvil S; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Ray R; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Liguori A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Kalyuzhniy O; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Wang X; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Warner JE; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Weldon SR; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Dale GA; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Kirsch KH; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Nair U; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Baboo S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Georgeson E; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Adachi Y; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Kubitz M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Jackson AM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Richey ST; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Volk RM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Lee JH; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Diedrich JK; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Prum T; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA., Falcone S; Moderna Inc., Cambridge, MA 02139, USA., Himansu S; Moderna Inc., Cambridge, MA 02139, USA., Carfi A; Moderna Inc., Cambridge, MA 02139, USA., Yates JR 3rd; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Paulson JC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA., Sok D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA., Ward AB; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Schief WR; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02139, USA., Batista FD; The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

المصدر: Science (New York, N.Y.) [Science] 2024 May 17; Vol. 384 (6697), pp. eadk0582. Date of Electronic Publication: 2024 May 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

مواضيع طبية MeSH: AIDS Vaccines*/immunology , Broadly Neutralizing Antibodies*/immunology , Germinal Center*/immunology , HIV Antibodies*/immunology , HIV-1*/immunology , HIV-1*/genetics , Immunization, Secondary* , Nanoparticles* , mRNA Vaccines*/immunology, Animals ; Humans ; Mice ; B-Lymphocytes/immunology ; Cross Reactions ; Gene Knock-In Techniques ; HIV Envelope Protein gp120/immunology ; HIV Envelope Protein gp120/chemistry ; HIV Envelope Protein gp120/genetics ; HIV Infections/immunology ; HIV Infections/prevention & control ; Liposomes ; Memory B Cells/immunology ; Receptors, Antigen, B-Cell/immunology ; Receptors, Antigen, B-Cell/genetics ; Somatic Hypermutation, Immunoglobulin ; Female ; Mice, Inbred C57BL

المؤلفون: Baker R Jr; Department of Veterinary and Animal Sciences, College of Natural Science, University of Massachusetts Amherst, Amherst, MA, United States., Lawlor R; Department of Veterinary and Animal Sciences, College of Natural Science, University of Massachusetts Amherst, Amherst, MA, United States., Smith M; Department of Veterinary and Animal Sciences, College of Natural Science, University of Massachusetts Amherst, Amherst, MA, United States., Price J; Department of Veterinary and Animal Sciences, College of Natural Science, University of Massachusetts Amherst, Amherst, MA, United States., Eaton A; Institute for Applied Life Sciences (IALS) Clinical Testing Center (ICTC), University of Massachusetts Amherst, Amherst, MA, United States., Lover A; Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, United States., Alfandari D; Department of Veterinary and Animal Sciences, College of Natural Science, University of Massachusetts Amherst, Amherst, MA, United States., Reinhart P; Institute for Applied Life Sciences (IALS), University of Massachusetts Amherst, Amherst, MA, United States., Arcaro KF; Department of Veterinary and Animal Sciences, College of Natural Science, University of Massachusetts Amherst, Amherst, MA, United States., Osborne BA; Department of Veterinary and Animal Sciences, College of Natural Science, University of Massachusetts Amherst, Amherst, MA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 May 15; Vol. 15, pp. 1401209. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2*/immunology , Antibodies, Viral*/immunology , Antibodies, Viral*/blood , COVID-19*/immunology , COVID-19*/prevention & control , Saliva*/immunology , Saliva*/virology , COVID-19 Vaccines*/immunology , Immunization, Secondary* , Spike Glycoprotein, Coronavirus*/immunology, Humans ; Male ; Female ; Adult ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/blood ; Middle Aged ; Antibody Formation/immunology ; Young Adult

SCR Organism: SARS-CoV-2 variants